Pharmacology

Resource Center

Research Summaries

Research Summary
Research Summary
04/24/2026
Ashton L. Stahl
A stepped-wedge cluster randomized trial evaluated whether pairing electronic decision support with routine medication reviews increases deprescribing of potentially inappropriate medications among older...
04/24/2026
Guideline Update
Guideline Update
03/18/2026
Anthony Calabro, MA
New guideline recommendations from the ACC/AHA and 9 partner organizations prioritize earlier treatment, refined atherosclerotic cardiovascular disease risk prediction, and broader use of lipid biomarkers...
03/18/2026
Research Summary
Research Summary
12/17/2025
Ashton L. Stahl
In a prospective cohort of children in California who were prenatally exposed to selective serotonin reuptake inhibitors (SSRIs), investigators examined whether additional exposure to SSRIs via breast milk...
12/17/2025
Research Summary
Research Summary
06/10/2024

Anthony Calabro, MA

Anthony Calabro, MA
In this multicenter, phase 3 randomized-controlled trial, researchers evaluated the efficacy and safety of SHR8028, a water-free cyclosporine solution, 0.1%, compared with vehicle in patients with dry eye...
06/10/2024
Research summary
Research summary
06/06/2024

Jessica Ganga

Jessica Ganga
Researchers conducted a meta-analysis to determine the global prevalence of unprescribed weight-loss product use, such as diet pills, among adolescents.
06/06/2024
Conference Coverage
Conference Coverage
05/31/2024
Jessica Ganga
Patients with melanoma and who are being treated with PD-1 inhibitors have an increased risk of experiencing immune-related neurologic adverse events, compared with patients who are not being treated with...
05/31/2024
Research summary
Research summary
05/23/2024

Jessica Ganga

Jessica Ganga
A team of researchers examined the possibility of harmful risks associated with the discontinuation of long-term benzodiazepine use in patients.
05/23/2024
Research Summary
Research Summary
05/22/2024

Jessica Ganga

Jessica Ganga
Researchers examined the risk of nephrolithiasis among patients with type 2 diabetes using SGLT2is for treatment.
05/22/2024
FDA Alert
FDA Alert
03/04/2024
Anthony Calabro, MA
The FDA approved irinotecan liposome with oxaliplatin, fluorouracil, and leucovorin as a first-line regimen for the management of patients with metastatic pancreatic adenocarcinoma.
03/04/2024
Research Summary
Research Summary
02/14/2024
Jessica Ganga
Researchers evaluated the early- and later-stage use of various anti-obesity medications in patients.
02/14/2024